Okami Medical announced today that it closed a $32.5 million financing round to support its catheter-based technologies. Aliso Viejo, California-based Okami develops multiple technologies for peripheral vascular occlusion. To date, it developed the LOBO (low-profile braided occluder) vascular occlusion system and the Sendero microcatheter. LOBO provides interventional physicians with a single-device, one-and-done solution for occluding […]
Okami Medical
FDA clears Okami Medical vascular occluder
Okami Medical today said it received FDA 510(k) clearance for its LOBO-5 Vascular Occluder. The Low-profile Braided Occluder (LOBO) system is designed to provide interventional physicians with single device for the occlusion of a wide range of peripheral arterial targets. It combines neurovascular-derived HDBraid technology to create a highly occlusive structure for fast and efficient […]
MedTech 100 roundup: Markets skid after strong stretch
Following a strong performance over the last couple of weeks, the medtech market experienced one of its most significant drop-offs in recent months amid investor worries over a rise in COVID-19 cases in some states. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 82.12 points at […]
Okami Medical raises $7.2m to support vascular occlusion system
Months after the first use of its LOBO vascular occlusion system on patients, Okami Medical has raised more than $7.2 million. The Aliso Viejo, Calif.–based company raised the money from 18 investors, according to an SEC Form D filed June 10. After securing FDA clearance in late 2019, Okami Medical announced the first use of […]
Okami Medical wins FDA clearance for vascular occlusion system
Okami Medical yesterday said it won FDA 510(k) clearance for its LOBO Vascular Occlusion System. The Low-Profile Braided Occluder (LOBO) system helps patients and physicians with the occlusion of peripheral blood vessels. The system uses HDBraid technology to give physicians a minimally invasive platform for rapid and focal occlusion of a wide range of arterial […]
